Clinical strength

There are 1518 Digital Health ventures with an Evidence Signal > 40, indicating that they have generated evidence to confirm the medical benefit of their solution to the target customer. The average maturity of ventures on this list is 58.9.

Last Updated: September 22, 2022

Ventures

ShowEntries

Startup	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding	Track
10x Genomics	Omics Related Research	United States	$ 123.46 B	$ 123.46 B	IPO	$ 390.00 M	Toggle
11 Health and Technologies	Disease Management	United Kingdom	$ 123.46 B	$ 123.46 B	Seed	$ 1.71 M	Toggle
23andMe	Omics Related Applications	United States	$ 123.46 B	$ 123.46 B	SPAC	$ 600.00 M	Toggle
2Gether (טוגדר מוזיקה בע"מ)	Wellness Apps	Israel	$ 123.46 B	$ 123.46 B		undisclosed	Toggle
3billion (쓰리빌리언)	Diagnosis Tools	South Korea	$ 123.46 B	$ 123.46 B	Series C	$ 12.36 M	Toggle
3D Medicine (思路迪)	Omics Related Diagnosis	China	$ 123.46 B	$ 123.46 B	Series H	$ 229.02 M	Toggle
3Shape	Medical Imaging	Denmark	$ 123.46 B	$ 123.46 B	Grant	$ 0.16 M	Toggle
6Degrees (6מעלות)	Smart Equipment	Israel	$ 123.46 B	$ 123.46 B	Grant	$ 0.06 M	Toggle
ABCDx	Digital Therapeutics	Switzerland	$ 123.46 B	$ 123.46 B	Seed	undisclosed	Toggle
AbCellera	Drug Discovery	Canada	$ 123.46 B	$ 123.46 B	Grant	$ 1.51 M	Toggle

Showing 1 to 10 of 1511 entries